Modulation of cytochrome P450 1A1-mediated oxidation of benzo[a]pyrene by NADH and cytochrome b5

被引：1

作者：

Indra, Radek ^{[1
]}

Moserova, Michaela ^{[1
]}

Volker, Arlt M. ^{[2
]}

Stiborova, Marie ^{[1
]}

机构：

[1] Charles Univ Prague, Dept Biochem, Fac Sci, Prague 2, Czech Republic

[2] Kings Coll London, Analyt & Environm Sci Div, MRC PHE Ctr Environm & Hlth, London WC2R 2LS, England

来源：

TOXICOLOGY LETTERS | 2014年 / 229卷

关键词：

D O I：

10.1016/j.toxlet.2014.06.525

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

P-3.16

引用

页码：S150 / S150

页数：1

共 50 条

[31] Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats [J].

Stiborova, Marie ;

Dracinska, Helena ;

Borek-Dohalska, Lucie ;

Klusonova, Zuzana ;

Holecova, Jana ;

Martinkova, Marketa ;

Schmeiser, Heinz H. ;

Arlt, Volker M. .

TOXICOLOGY, 2018, 400 :48-56

[32] Comparison of cytochrome b5 interactions with some human cytochrome P450 isoforms [J].

Zhao, Chunsheng ;

Roberts, Arthur G. ;

Gao, Qiuxia ;

Atkins, William M. ;

Nelson, Sidney D. .

DRUG METABOLISM REVIEWS, 2011, 43 :31-31

[33] The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b5 [J].

Im, Sang-Choul ;

Waskell, Lucy .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 507 (01) :144-153

[34] Chlorzoxazone Metabolism by Porcine Cytochrome P450 Enzymes and the Effect of Cytochrome b5 [J].

Wiercinska, P. ;

Squires, E. J. .

DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) :857-862

[35] Cytochrome b5 Binds Tightly to Several Human Cytochrome P450 Enzymes [J].

Kim, Donghak ;

Kim, Vitchan ;

Tateishi, Yasuhiro ;

Guengerich, F. Peter .

DRUG METABOLISM AND DISPOSITION, 2021, 49 (10) :902-909

[36] NADPH- and NADH-dependent formation of DNA adducts by benzo[a] pyrene catalyzed with cytochrome P450 1A1 [J].

Moserova, M. ;

Indra, R. ;

Milichovsky, J. ;

Frei, E. ;

Schmeiser, H. H. ;

Arlt, V. M. ;

Stiborova, M. .

TOXICOLOGY LETTERS, 2015, 238 (02) :S239-S239

[37] Application of hepatic cytochrome b5/P450 reductase null (HBRN) mice to study the role of cytochrome b5 in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine [J].

Reed, Lindsay ;

Indra, Radek ;

Mrizova, Iveta ;

Moserova, Michaela ;

Schmeiser, Heinz H. ;

Wolf, C. Roland ;

Henderson, Colin J. ;

Stiborova, Marie ;

Phillips, David H. ;

Arlt, Volker M. .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 366 :64-74

[38] Defining the in Vivo Role for Cytochrome b5 in Cytochrome P450 Function through the Conditional Hepatic Deletion of Microsomal Cytochrome b5 [J].

Finn, Robert D. ;

McLaughlin, Lesley A. ;

Ronseaux, Sebastien ;

Rosewell, Ian ;

Houston, J. Brian ;

Henderson, Colin J. ;

Wolf, C. Roland .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (46) :31385-31393

[39] Evidence That Cytochrome b5 and Cytochrome b5 Reductase Can Act as Sole Electron Donors to the Hepatic Cytochrome P450 Systems [J].

Henderson, Colin J. ;

McLaughlin, Lesley A. ;

Wolf, C. Roland .

MOLECULAR PHARMACOLOGY, 2013, 83 (06) :1209-1217

[40] Identification of the binding site on cytochrome P4502B4 for cytochrome b5 and cytochrome P450 reductase* [J].

Bridges, A ;

Gruenke, L ;

Changi, YT ;

Vakser, IA ;

Loewi, G ;

Waskell, L .

FASEB JOURNAL, 2000, 14 (08) :A1307-A1307

← 1 2 3 4 5 →